Oakstone The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020

Oakstone The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020

$10.00

+ Include: 59 videos + 2 pdfs, size: 7.63 GB

+ Target Audience: hematologists, oncologists

Description

+ Include: 59 videos + 2 pdfs, size: 7.63 GB

+ Target Audience: hematologists, oncologists

+ Sample video: contact me for sample video

+ Information:

Improve Patient Care in Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. In this CME program, expert speakers address relevant topics in case-based board review presentations. Improve patient care by learning to:

  • Perform differential diagnosis of complex hematologic and oncologic disorders
  • Identify and apply current therapeutic options for hematologic and oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to hematology and oncology
  • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
  • Apply new knowledge to the ABIM certification/recertification hematology and oncology examinations

Date Of Original Release: April 15, 2020

 

+ Topics:

1. Molecular Genetics of Cancer.mp4

2. Advances in Cancer Drug Development.mp4

3. Infections in Cancer Patients.mp4

4. Symptom Management in Patients with Cancer.mp4

5. Communication – The Key to Excellence in End-of-Life Care.mp4

6. Biology of Hematopoietic Stem Cell Transplantation.mp4

7. Biology of Acute Leukemia & Myelodysplastic Syndromes.mp4

8. Acute Leukemias.mp4

9. Myelodysplastic Syndrome.mp4

10. Chronic Myelogenous Leukemia.mp4

11. Myeloproliferative Syndromes.mp4

12. Multiple Myeloma.mp4

13. Waldenstrom Macroglobulemia & Amyloidosis.mp4

14. Low Grade Lymphomas.mp4

15. High Grade Lymphomas.mp4

16. Hodgkin’s Lymphoma.mp4

17. Diagnosis & Treatment of CLL & Related B Cell Malignancies.mp4

18. Head & Neck Cancer.mp4

19. Natural History, Screening, Surgery & Small Cell Lung Cancer.mp4

20. Non Small Cell Lung Cancer.mp4

21. Mesothelioma & Thymoma.mp4

22. Thyroid Cancer.mp4

23. Carcinoid & Pancreatic Neuroendocrine Tumors.mp4

24. Esophageal & Gastric Cancer.mp4

25. Pancreatic & Hepatobiliary Cancer.mp4

26. Anal Cancers.mp4

27. Colorectal Cancers.mp4

28. Gastrointestinal Cancer – Genetic Syndromes.mp4

29. Germ Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy.mp4

30. Renal & Bladder Cancer.mp4

31. Prostate Cancer Part I – Overview & Management of Localized Disease.mp4

32. Prostate Cancer Part II – Management of Disseminated Prostate Cancer.mp4

33. Melanoma.mp4

34. Sarcomas & Gastrointestinal Stromal Tumors (GIST).mp4

35. Ovarian Cancer.mp4

36. Cervical & Endometrial Cancer.mp4

37. Neuro-oncology.mp4

38. Breast Cancer – Risk Factors, Genetics, Screening & Prevention.mp4

39. Multimodality Therapy for Early Stage Breast Cancer – Part 1 – Surgery & Radiation.mp4

40. Multimodality Therapy for Early Stage Breast Cancer – Part 2 – Systemic Therapy.mp4

41. Management of Metastatic Breast Cancer.mp4

42. Breast Cancer Survivorship.mp4

43. Hematopoiesis & Cytokines.mp4

44. Acquired Bone Marrow Failure.mp4

45. Congenital Bone Marrow Failure.mp4

46. Hemophagocytic Syndromes & Related Immunodeficiencies.mp4

47. Anemia – An Overview.mp4

48. Iron Deficiency & Iron Overload.mp4

49. Immune Hemolytic Anemia.mp4

50. Non-immune Hemolytic Anemia.mp4

51. Sickle Cell Disease.mp4

52. Thalassemia & Other Hemoglobinopathies.mp4

53. Disorders of Neutrophils.mp4

54. Acquired Thrombocytopenias.mp4

55. Hemophilia.mp4

56. Von Willebrand Disease & Congenital Platelet Disorders.mp4

57. Congenital & Acquired Thrombophilia.mp4

58. Use of Direct Oral Anticoagulants in Clinical Practice.mp4

59. Transfusion Medicine for the Clinician.mp4

Questions.pdf

Syllabus.pdf

Reviews

There are no reviews yet.

Be the first to review “Oakstone The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020”

Your email address will not be published. Required fields are marked *

Related Products